219 related articles for article (PubMed ID: 25560789)
1. Various regimens for prophylactic treatment of patients with haemophilia.
Schwarz R; Ljung R; Tedgård U
Eur J Haematol; 2015 Feb; 94 Suppl 77():11-6. PubMed ID: 25560789
[TBL] [Abstract][Full Text] [Related]
2. Forum on: the role of recombinant factor VIII in children with severe haemophilia A.
Franchini M; Coppola A; Molinari AC; Santoro C; Schinco P; Speciale V; Tagliaferri A
Haemophilia; 2009 Mar; 15(2):578-86. PubMed ID: 19187188
[TBL] [Abstract][Full Text] [Related]
3. Optimizing factor prophylaxis for the haemophilia population: where do we stand?
Blanchette VS; Manco-Johnson M; Santagostino E; Ljung R
Haemophilia; 2004 Oct; 10 Suppl 4():97-104. PubMed ID: 15479380
[TBL] [Abstract][Full Text] [Related]
4. Tailored frequency-escalated primary prophylaxis for severe haemophilia A: results of the 16-year Canadian Hemophilia Prophylaxis Study longitudinal cohort.
Feldman BM; Rivard GE; Babyn P; Wu JKM; Steele M; Poon MC; Card RT; Israels SJ; Laferriere N; Gill K; Chan AK; Carcao M; Klaassen RJ; Cloutier S; Price VE; Dover S; Blanchette VS
Lancet Haematol; 2018 Jun; 5(6):e252-e260. PubMed ID: 29731369
[TBL] [Abstract][Full Text] [Related]
5. Experience with central venous access devices (CVADs) in the Canadian hemophilia primary prophylaxis study (CHPS).
Langley AR; Stain AM; Chan A; McLimont M; Chait S; Wu J; Poon MC; Card R; Israels SJ; Laferriere N; Klaassen RJ; Rivard GE; Cloutier S; Hawes S; Feldman B; Blanchette V
Haemophilia; 2015 Jul; 21(4):469-76. PubMed ID: 26104147
[TBL] [Abstract][Full Text] [Related]
6. Effects of primary and secondary prophylaxis on the clinical expression of joint damage in children with severe haemophilia A. Results of a multicenter non-concurrent cohort study.
Schobess R; Kurnik K; Friedrichs F; Halimeh S; Krümpel A; Bidlingmaier C; Nowak-Göttl U
Thromb Haemost; 2008 Jan; 99(1):71-6. PubMed ID: 18217137
[TBL] [Abstract][Full Text] [Related]
7. Prevention of arthropathy in haemophilia: prophylaxis.
Santagostino E; Mancuso ME
Haemophilia; 2008 Nov; 14 Suppl 6():16-9. PubMed ID: 19134028
[TBL] [Abstract][Full Text] [Related]
8. Prophylaxis for severe haemophilia: clinical challenges in the absence as well as in the presence of inhibitors.
Fischer K; Valentino L; Ljung R; Blanchette V
Haemophilia; 2008 Jul; 14 Suppl 3():196-201. PubMed ID: 18510542
[TBL] [Abstract][Full Text] [Related]
9. Cost-utility analysis of Canadian tailored prophylaxis, primary prophylaxis and on-demand therapy in young children with severe haemophilia A.
Risebrough N; Oh P; Blanchette V; Curtin J; Hitzler J; Feldman BM
Haemophilia; 2008 Jul; 14(4):743-52. PubMed ID: 18422610
[TBL] [Abstract][Full Text] [Related]
10. Bleeding before prophylaxis in severe hemophilia: paradigm shift over two decades.
Nijdam A; Altisent C; Carcao MD; Cid AR; Claeyssens-Donadel S; Kurnik K; Ljung R; Nolan B; Petrini P; Platokouki H; Rafowicz A; Thomas AE; Fischer K;
Haematologica; 2015 Mar; 100(3):e84-6. PubMed ID: 25527565
[No Abstract] [Full Text] [Related]
11. Effect of late prophylaxis in hemophilia on joint status: a randomized trial.
Manco-Johnson MJ; Lundin B; Funk S; Peterfy C; Raunig D; Werk M; Kempton CL; Reding MT; Goranov S; Gercheva L; Rusen L; Uscatescu V; Pierdominici M; Engelen S; Pocoski J; Walker D; Hong W
J Thromb Haemost; 2017 Nov; 15(11):2115-2124. PubMed ID: 28836341
[TBL] [Abstract][Full Text] [Related]
12. How to achieve full prophylaxis in young boys with severe haemophilia A: different regimens and their effect on early bleeding and venous access.
Nijdam A; Kurnik K; Liesner R; Ljung R; Nolan B; Petrini P; Fischer K;
Haemophilia; 2015 Jul; 21(4):444-50. PubMed ID: 25582494
[TBL] [Abstract][Full Text] [Related]
13. Strategies for reducing inhibitor formation in severe haemophilia.
Tunstall O; Astermark J
Eur J Haematol; 2015 Feb; 94 Suppl 77():45-50. PubMed ID: 25560794
[TBL] [Abstract][Full Text] [Related]
14. A comparison of traditional vs. Canadian tailored prophylaxis dosing of prophylactic factor infusions in children with haemophilia A and B in a single hemophilia treatment center.
Dodd C; Watts RG
Haemophilia; 2012 Jul; 18(4):561-7. PubMed ID: 22221939
[TBL] [Abstract][Full Text] [Related]
15. Low-dose tertiary prophylactic therapy reduces total number of bleeds and improves the ability to perform activities of daily living in adults with severe haemophilia A: a single-centre experience from Beijing.
Hua B; Lian X; Li K; Lee A; Poon MC; Zhao Y
Blood Coagul Fibrinolysis; 2016 Mar; 27(2):136-40. PubMed ID: 26258677
[TBL] [Abstract][Full Text] [Related]
16. Joint outcomes in patients with haemophilia: the importance of adherence to preventive regimens.
Berntorp E
Haemophilia; 2009 Nov; 15(6):1219-27. PubMed ID: 19659939
[TBL] [Abstract][Full Text] [Related]
17. Tailored prophylaxis in severe hemophilia A: interim results from the first 5 years of the Canadian Hemophilia Primary Prophylaxis Study.
Feldman BM; Pai M; Rivard GE; Israels S; Poon MC; Demers C; Robinson S; Luke KH; Wu JK; Gill K; Lillicrap D; Babyn P; McLimont M; Blanchette VS;
J Thromb Haemost; 2006 Jun; 4(6):1228-36. PubMed ID: 16706965
[TBL] [Abstract][Full Text] [Related]
18. [Prevention of joint damage in hemophilic children with early prophylaxis].
Kreuz W; Escuriola Ettingshausen C; Funk M; Pons S; Schmidt H; Kornhuber B
Orthopade; 1999 Apr; 28(4):341-6. PubMed ID: 10335528
[TBL] [Abstract][Full Text] [Related]
19. Radiologic evaluation of prophylaxis in severe haemophilia.
Pettersson H; Nilsson IM; Hedner U; Noréhn K; Ahlberg A
Acta Paediatr Scand; 1981 Jul; 70(4):565-70. PubMed ID: 6797235
[TBL] [Abstract][Full Text] [Related]
20. [French guidelines. Long-term prophylaxis for severe haemophilia A and B children to prevent haemophiliac arthropathy].
Meunier S; Trossaërt M; Berger C; Borel-Derlon A; Dirat G; Donadel-Claeyssens S; Assolant AD; Guérois C; Lutz P; Rafowicz A; Rothschild C; Chambost H;
Arch Pediatr; 2009 Dec; 16(12):1571-8. PubMed ID: 19960603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
